Inventor

Zhengfang Kang

Inventor

Raleigh, NC, US

Overview

2→

Patents

2011–2021

Patent span

Chemistry

Primary field (CPC C)

Patents· 2 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations11%

C07BGeneral methods of organic chemistry11%

C07CAcyclic or carbocyclic compounds11%

C07DHeterocyclic compounds11%

C07HSugars11%

C12NMicroorganisms or enzymes11%

C12PFermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture11%

C12YEnzymes11%

Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution11%

PatentTitleYear

11,130,977Processes for producing fermentation products2021 8,039,513'Cis-1,2-substituted stilbene derivatives and their use in preparation of drugs for treatment and/or prevention of diabetes'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011Patents assigned to INST RADIATION MED AMMS PLA (1)· patent assignee history

2011Based in Beijing, CN· patent location history

2021Patents assigned to NOVOZYMES AS (1)· patent assignee history

2021Based in Raleigh, NC, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
INST RADIATION MED AMMS PLA	1	2011
NOVOZYMES AS	1	2021

Locations

Location	Patents	Span
Raleigh, NC, US	1	2021
Beijing, CN	1	2011